Results 191 to 200 of about 33,509 (296)

Antilipolytic Activity of a Novel Partial A1Adenosine Receptor Agonist Devoid of Cardiovascular Effects: Comparison with Nicotinic Acid [PDF]

open access: green, 2007
Arvinder K. Dhalla   +5 more
openalex   +1 more source

Characteristics of Drug‐Related Deaths Among Individuals Engaged in Sex Work in the United Kingdom, 1997–2023

open access: yesDrug and Alcohol Review, Volume 44, Issue 6, Page 1805-1810, September 2025.
ABSTRACT Introduction Individuals engaged in sex work are an understudied population recognised to be at differential risk of experiencing drug‐related harms. We aimed to determine the case characteristics, circumstances of death and type of implicated drugs among sex workers dying due to drug‐related causes.
Emmert Roberts   +2 more
wiley   +1 more source

Nicotinic Acid Receptor Agonists Differentially Activate Downstream Effectors [PDF]

open access: hybrid, 2007
Jeremy G. Richman   +17 more
openalex   +1 more source

Real‐world insights into incretin‐based therapy: Associations between changes in taste perception and appetite regulation in individuals with obesity and overweight: A cross‐sectional study

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue 9, Page 5008-5018, September 2025.
Abstract Aims This cross‐sectional study examined associations between self‐reported taste perception changes and appetite‐related outcomes in individuals with obesity treated with glucagon‐like peptide‐1 receptor agonist (GLP‐1 RAS) or dual glucose‐dependent insulinotropic polypeptide (GIP)/GLP‐1 RAS in real‐world conditions.
Ali Kapan   +4 more
wiley   +1 more source

d‐amino acids: new functional insights

open access: yesThe FEBS Journal, Volume 292, Issue 17, Page 4395-4417, September 2025.
This review explores recent advances in understanding d‐amino acids (d‐AAs) and their pivotal roles across organisms, from plants to humans. d‐AAs have been implicated in key physiological processes, including cancer, inflammation, immune regulation, kidney disease, diabetes, and nervous system function.
Loredano Pollegioni   +5 more
wiley   +1 more source

A structural model of agonist binding to the α3β4 neuronal nicotinic receptor

open access: green, 2003
Valéria Catelli Infantozzi Costa   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy